MoneyWorks4Me

Ind-Swift gets renewed approval for Global Business Unit

30 May 2025 Evaluate

Ind-Swift has received renewed approval for its 100% Export Oriented Unit (Global Business Unit (GBU)) situated at Punjab for a period of three years from Medicines & Healthcare Products Regulatory Agency (MHRA), London, United Kingdom. The approval is based on the assessment undertaken by the agency of company’s quality metrics and quality systems.

Ind-Swift is Chandigarh based pharmaceutical company, established in 1986 with a mission of winning global customers through innovative pharmaceutical products.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..